Nucor (NYSE:NUE) Stock Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/16/2024 | 23.93% | UBS | → $210 | Initiates Coverage On | → Buy |
| 12/12/2023 | -6.75% | JP Morgan | $151 → $158 | Maintains | Neutral |
| 10/31/2023 | -9.12% | Morgan Stanley | $162 → $154 | Maintains | Equal-Weight |
| 10/16/2023 | -10.89% | JP Morgan | → $151 | Upgrades | Underweight → Neutral |
| 09/08/2023 | -10.89% | JP Morgan | $150 → $151 | Maintains | Underweight |
| 07/27/2023 | 6.23% | Citigroup | $160 → $180 | Maintains | Neutral |
| 07/26/2023 | -4.39% | Morgan Stanley | $148 → $162 | Maintains | Equal-Weight |
| 07/11/2023 | -1.44% | Credit Suisse | $156 → $167 | Maintains | Outperform |
| 07/05/2023 | 12.72% | Exane BNP Paribas | → $191 | Upgrades | Neutral → Outperform |
| 06/21/2023 | -12.66% | Morgan Stanley | → $148 | Reiterates | → Equal-Weight |
| 06/01/2023 | — | Wolfe Research | Upgrades | Underperform → Peer Perform | |
| 05/23/2023 | -23.28% | JP Morgan | → $130 | Initiates Coverage On | → Underweight |
| 05/22/2023 | -12.66% | Morgan Stanley | $133 → $148 | Maintains | Equal-Weight |
| 04/24/2023 | -21.51% | Morgan Stanley | $131 → $133 | Maintains | Equal-Weight |
| 03/20/2023 | -22.69% | Morgan Stanley | $122 → $131 | Maintains | Equal-Weight |
| 03/17/2023 | -7.93% | Credit Suisse | $140 → $156 | Maintains | Outperform |
| 03/13/2023 | -4.98% | Goldman Sachs | $144 → $161 | Maintains | Neutral |
| 03/10/2023 | -4.98% | Goldman Sachs | $144 → $161 | Maintains | Neutral |
| 01/30/2023 | -28% | Morgan Stanley | $113 → $122 | Maintains | Equal-Weight |
| 01/27/2023 | -2.62% | BMO Capital | $155 → $165 | Maintains | Market Perform |
| 01/04/2023 | 1.51% | B of A Securities | → $172 | Reinstates | → Buy |
| 12/06/2022 | -14.43% | UBS | $120 → $145 | Maintains | Neutral |
| 11/09/2022 | -16.2% | BMO Capital | $113 → $142 | Maintains | Market Perform |
| 10/24/2022 | -33.31% | Morgan Stanley | $115 → $113 | Maintains | Equal-Weight |
| 10/06/2022 | -32.72% | Goldman Sachs | $127 → $114 | Maintains | Neutral |
| 09/16/2022 | -17.38% | Credit Suisse | $165 → $140 | Maintains | Outperform |
| 07/25/2022 | -32.13% | Morgan Stanley | $121 → $115 | Maintains | Equal-Weight |
| 07/06/2022 | -28.59% | Morgan Stanley | $144 → $121 | Maintains | Equal-Weight |
| 06/14/2022 | -26.23% | JP Morgan | $146 → $125 | Maintains | Neutral |
| 05/31/2022 | -23.28% | Goldman Sachs | $148 → $130 | Maintains | Neutral |
| 05/11/2022 | -15.02% | Morgan Stanley | $108 → $144 | Maintains | Equal-Weight |
| 04/25/2022 | 12.13% | Argus Research | $140 → $190 | Maintains | Buy |
| 04/22/2022 | -12.66% | Goldman Sachs | $134 → $148 | Maintains | Neutral |
| 04/22/2022 | 3.28% | Credit Suisse | $142 → $175 | Maintains | Outperform |
| 03/24/2022 | -23.87% | JP Morgan | $113 → $129 | Maintains | Neutral |
| 02/16/2022 | -29.18% | Goldman Sachs | $114 → $120 | Maintains | Neutral |
| 01/31/2022 | -36.26% | Morgan Stanley | $107 → $108 | Maintains | Equal-Weight |
| 01/11/2022 | -39.8% | Wolfe Research | → $102 | Downgrades | Peer Perform → Underperform |
| 11/17/2021 | -38.62% | Wolfe Research | → $104 | Initiates Coverage On | → Peer Perform |
| 10/26/2021 | -36.85% | Morgan Stanley | $105 → $107 | Maintains | Equal-Weight |
| 10/06/2021 | -36.26% | Goldman Sachs | $123 → $108 | Downgrades | Buy → Neutral |
| 09/15/2021 | -23.28% | Deutsche Bank | $100 → $130 | Maintains | Hold |
| 08/24/2021 | -23.28% | Seaport Global | → $130 | Initiates Coverage On | → Buy |
| 07/01/2021 | -40.98% | Deutsche Bank | $75 → $100 | Maintains | Hold |
| 06/16/2021 | -32.72% | JP Morgan | → $114 | Initiates Coverage On | → Neutral |
| 06/14/2021 | -40.39% | Morgan Stanley | $95 → $101 | Maintains | Equal-Weight |
| 05/11/2021 | -43.93% | Morgan Stanley | $71 → $95 | Maintains | Equal-Weight |
| 04/20/2021 | -52.79% | B of A Securities | $56 → $80 | Upgrades | Underperform → Neutral |
| 04/12/2021 | — | Goldman Sachs | Initiates Coverage On | → Buy | |
| 04/09/2021 | -49.25% | Goldman Sachs | → $86 | Initiates Coverage On | → Buy |
| 03/19/2021 | -49.84% | Argus Research | → $85 | Upgrades | Hold → Buy |
| 03/12/2021 | -58.1% | Morgan Stanley | $60 → $71 | Maintains | Equal-Weight |
| 02/03/2021 | -62.82% | Credit Suisse | → $63 | Upgrades | Neutral → Outperform |
| 12/09/2020 | -64.59% | Morgan Stanley | → $60 | Initiates Coverage On | → Equal-Weight |
| 11/20/2020 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 10/15/2020 | -71.67% | Exane BNP Paribas | → $48 | Downgrades | Outperform → Neutral |
| 08/11/2020 | — | Argus Research | Downgrades | Buy → Hold | |
| 06/10/2020 | -71.08% | Keybanc | $45 → $49 | Maintains | Overweight |
| 05/14/2020 | -76.98% | UBS | $56 → $39 | Maintains | Neutral |
| 05/13/2020 | -73.44% | Keybanc | $49 → $45 | Maintains | Overweight |
| 04/29/2020 | -75.21% | BMO Capital | $35 → $42 | Maintains | Market Perform |
| 04/17/2020 | -75.21% | JP Morgan | $57 → $42 | Maintains | Overweight |
| 03/30/2020 | -75.8% | Goldman Sachs | $55 → $41 | Upgrades | Neutral → Buy |
| 03/24/2020 | -74.62% | Keybanc | $60 → $43 | Maintains | Overweight |
| 03/20/2020 | -68.13% | Credit Suisse | $57 → $54 | Maintains | Outperform |
| 02/18/2020 | -64.59% | Keybanc | $62 → $60 | Maintains | Overweight |
| 01/31/2020 | -67.54% | Goldman Sachs | $60 → $55 | Downgrades | Buy → Neutral |
| 01/29/2020 | -66.36% | Credit Suisse | $61 → $57 | Maintains | Outperform |
| 01/29/2020 | — | Deutsche Bank | Downgrades | Hold → Sell | |
| 12/09/2019 | — | Longbow Research | Upgrades | Neutral → Buy | |
| 11/14/2019 | -66.95% | UBS | $57 → $56 | Maintains | Neutral |
| 11/13/2019 | -63.41% | Keybanc | $60 → $62 | Maintains | Overweight |
| 08/27/2019 | -64.59% | Keybanc | $61 → $60 | Maintains | Overweight |
| 06/17/2019 | -64% | Keybanc | $66 → $61 | Maintains | Overweight |
| 06/04/2019 | -65.18% | Goldman Sachs | $70 → $59 | Maintains | Buy |
| 05/31/2019 | -70.49% | B of A Securities | $68 → $50 | Downgrades | Buy → Underperform |
| 05/22/2019 | -61.05% | Keybanc | $70 → $66 | Maintains | Overweight |
| 03/11/2019 | — | Longbow Research | Downgrades | Buy → Neutral |